Treatment of plasma cell leukemia in patients under 70 years [Traitement des leucémies primitives à plasmocytes du sujets de moins de 70 ans]
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2016
At a glance
- Drugs Bortezomib (Primary) ; Doxorubicin liposomal (Primary) ; Lenalidomide (Primary)
- Indications Plasma cell leukaemia
- Focus Therapeutic Use
- Acronyms AOL09-DrROYER
- 25 Apr 2016 Status changed from active, no longer recruiting to completed according to results published in the Journal of Clinical Oncology.
- 25 Apr 2016 Results published in the Journal of Clinical Oncology
- 01 Jul 2013 Status changed from recruiting to active, no longer recruiting according to results published in the Journal of Clinical Oncology.